and include the spectrum of the relatively chemotherapy-sensitive anaplastic oligodendrogliomas (AOs), the more chemotherapy refractory anaplastic astrocytomas (AAs) and mixed oligoastrocytomas ...

A total of 58% of patients with malignant astrocytomas achieved a complete or partial response to therapy, but only partial responses were noted in anaplastic oligodendroglioma patients (52%).